Background: In the past ten years, methotrexate (MTX) has appeared as an alternative for the treatment of systemic lupus erythematosus (SLE).
Aim: To evaluate the use of MTX and the results of treatment in a group of patients with SLE.
Patients And Methods: Retrospective review of 426 files of patients with SLE.